Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Further Publications ImmunologyFurther Publications Rheumatology

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration

Adv Ther

Navarro-Compán V, Reveille JD, Rahman P, Maldonado-Cocco JA, Magrey M, Bolce R, Panni T, Kronbergs A, Rudwaleit M

doi: 10.1007/s12325-025-03305-5

Further Publications Rheumatology

Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis-data from a Portuguese registry

Rheumatology (Oxford)

Silva SP, Monteiro B, Pinto Oliveira C, Pereira da Costa R, Matos CO, Lopes MD, Gomes CM, Bernardes M, Santos ME, Gago L, Abreu C, Fraga V, Mendes B, Lucas Rocha M, Soares CD, Silva C, Santos H, Valente P, Silva L, Eugénio G, Barcelos A

doi: 10.1093/rheumatology/keaf176

Further Publications Rheumatology

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study

Rheumatology (Oxford)

Poddubnyy D, Sieper J, Akar S, Muñoz-Fernández S, Haibel H, Protopopov M, Altmaier E, Ganz F, Inman RD

doi: 10.1093/rheumatology/keaf447

Rheumatoid Arthritis

Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial

Ann Rheum Dis

Berg IJ, Kristianslund EK, Tveter AT, Sexton J, Bakland G, Gossec L, Hakim S, Macfarlane GJ, Moholt E, Provan SA, Thomassen EEK, de Thurah A, Haavardsholm EA, Lillegraven S, Osteras N

doi: 10.1016/j.ard.2025.04.019

Rheumatoid Arthritis

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

Rheumatology (Oxford)

Serrano-Combarro A, Atienza-Mateo B, Martín-Gutierrez A, Ibarrola Paino L, Casafont-Solé I, Loarce-Martos J, Blanco-Madrigal JM, Ortega-Castro R, Mena-Vázquez N, Fernández-Díaz C, Loricera J, Ferrer D, Castañeda S, Blanco R, Spanish Collaborative Group of Interstitial Lung Disease Associated with Rheumatoid Arthritis

doi: 10.1093/rheumatology/keag023

Further Publications Rheumatology

Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome

Arthritis Res Ther

Bertsias A, Flouri I, Emmanouilidou E, Repa A, Avgoustidis N, Kalogiannaki E, Pitsigavdaki S, Bertsias G, Sidiropoulos P

doi: 10.1186/s13075-026-03732-x

Psoriatic Arthritis

Relationship of radiographic progression status to low disease activity in patients with psoriatic arthritis receiving secukinumab treatment for two years

Rheumatology (Oxford)

Mease PJ, Coates LC, Gaillez C, Shew A, Bao W, Ritchlin CT

doi: 10.1093/rheumatology/keaf488

Rheumatoid Arthritis

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

Semin Arthritis Rheum

Llorca J, Ferraz-Amaro I, Castañeda S, Plaza Z, Sánchez-Alonso F, García-Gómez C, González-Juanatey C, González-Gay MÁ, CARMA Project Collaborative Group

doi: 10.1016/j.semarthrit.2025.152833

Related content

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Ixekizumab Improves Signs, Symptoms, and Quality of Life in Patients with Axial Spondyloarthritis Irrespective of Symptom Duration

Biologic disease-modifying antirheumatic drugs survival in late-onset axial spondyloarthritis-data from a Portuguese registry

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study

Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomised controlled noninferiority trial

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

Difficult to manage axial spondyloarthritis patients have high burden of pain-related comorbidities and adverse long-term outcome

Relationship of radiographic progression status to low disease activity in patients with psoriatic arthritis receiving secukinumab treatment for two years

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort